How the Regulatory Affairs Landscape can change in the post Covid-19 Era: the road so far and the emerging trends
How the Regulatory Affairs Landscape can change in the post Covid-19 Era: […]
How the Regulatory Affairs Landscape can change in the post Covid-19 Era: […]
ASTM E2500 APPROACH, Process Equipment Suppliers and Qualification SMEs by Zoltan Langosco […]
Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. […]
New EU GMP Vol.4 Annex I and Environmental Monitoring leverage by: Alessio […]
How to perform a robust Vaccine Technology Transfer in a challenging era
Operational Technology and Cyber Security must walk hand in hand by Danilo Maruccia […]
Impact of possible removal of the Titanium dioxide from human medicines formulations […]
Technology Transfer has always been a hot topic and can be even more challenging for complex processes/products like biotechnological ones.
In this Covid-19 pandemic era, different companies are facing technology transfer processes as a mandatory way to boost their covid vaccines production and follow patients’ need, shifting a series of contract manufacturers across the world that must inherit their technology and achieve compliance in a really short timing to meet the production goals.
Pharmacovigilance Data: challenges for Pharmaceutical Companies by: Daniela Rota PV Unit Manager […]
Covid-19 & Pharmaceutical manufacturing: the challenges for production quality, safety and continuity